| Linsitinib |
ENSG00000005206.12 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000124915.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000125514.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000126005.11 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000135253.9 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000167912.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000172250.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000175061.13 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000175772.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000177337.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000177337.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000177738.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000177993.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000177993.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000178193.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000178947.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000180422.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000181097.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000182057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000182057.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000182109.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000182366.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000182376.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000182376.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000182404.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000182873.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000184274.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000185168.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000185186.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000185904.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000186019.10 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000186056.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000186056.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000187904.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000188365.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000196553.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000196553.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000197085.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000197813.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000198468.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000203279.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000203279.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000203280.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000203325.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000203356.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000203499.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000203506.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000203588.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000203709.5 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000203729.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000203849.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000203849.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000203865.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000203875.6 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000204044.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000204055.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000204272.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000204362.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000204380.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000204581.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000204625.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000204666.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000204684.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000204758.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000204758.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000204934.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000205015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000205054.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000205682.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000206140.5 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000206567.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000212163.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000214145.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000214146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000214401.4 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000214407.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000214432.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000214719.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000214733.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000214772.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000214803.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000214894.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000214922.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000215068.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000215159.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000215386.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000215447.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000215533.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000215808.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000215863.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000222032.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000222035.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000222042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000223382.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000223390.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000223442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000223478.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000223528.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000223571.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000223573.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000223635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000223692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000223692.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000223695.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000223725.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000223749.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000223768.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000223779.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000223779.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000223791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000223821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000223960.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000224020.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224032.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000224034.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000224050.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000224081.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000224081.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224081.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000224141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000224238.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000224238.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224292.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000224308.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000224409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000224424.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000224441.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000224481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000224511.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224715.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000224729.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000224799.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000224799.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000224905.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000224914.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000224950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000224950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000225111.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000225138.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000225146.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000225177.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000225195.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000225205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000225278.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000225330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000225353.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000225361.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000225361.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000225383.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000225393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000225408.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000225408.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000225506.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000225572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000225643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000225675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000225725.4 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000225806.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000225836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000225945.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000225953.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000225964.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000225981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000226009.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000226067.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000226091.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000226149.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000226167.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000226276.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000226310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000226317.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000226352.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000226377.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000226445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000226445.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000226508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000226533.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000226562.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000226609.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000226627.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000226637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000226637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000226674.4 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000226679.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000226699.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000226746.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000226833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000226851.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000226862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000226876.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000226877.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000226889.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000226900.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000226917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227014.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000227076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227076.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000227082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227136.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227172.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227192.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227214.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000227218.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227245.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000227256.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000227279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000227398.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000227403.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227403.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000227407.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000227477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227479.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000227481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227487.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000227543.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000227627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227674.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000227769.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000227848.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000227857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000227885.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000227953.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000228063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000228065.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000228079.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000228137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000228150.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000228201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228221.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228237.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000228261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000228274.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000228290.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000228340.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000228412.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000228412.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228412.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000228485.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000228487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000228509.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000228527.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000228554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000228566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228614.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000228624.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000228625.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000228661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000228679.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000228741.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000228786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000228794.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000228801.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000228817.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000228817.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000228839.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000228857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000228917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228951.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000228956.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000229017.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229036.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000229109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000229109.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000229124.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000229137.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000229195.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000229214.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000229261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000229368.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229404.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000229431.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229481.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000229487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229494.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000229512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000229647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229672.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000229694.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000229801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000229841.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000229862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000229931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000229950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000229970.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000229990.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000230054.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000230061.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000230105.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000230105.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000230148.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000230176.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000230212.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000230212.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000230310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000230319.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000230417.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000230433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000230438.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000230487.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000230499.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000230513.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000230530.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000230534.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000230537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000230537.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000230555.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000230647.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000230658.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000230698.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000230731.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000230735.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000230751.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000230789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000230798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000230812.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000230812.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000230834.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000230928.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000230937.5 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000230940.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000231010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231039.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000231104.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000231121.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231131.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000231154.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000231201.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000231201.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000231201.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000231242.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000231355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000231407.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000231429.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231429.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000231473.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000231485.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000231486.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000231507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000231519.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000231530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231551.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231551.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000231551.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000231607.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000231616.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000231616.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000231652.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231663.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000231663.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000231689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000231728.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231734.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231734.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000231734.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000231764.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231764.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000231871.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000231889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000231908.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000231966.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000231993.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000232019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000232093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000232098.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000232098.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000232116.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000232116.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000232151.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000232194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000232259.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000232284.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000232284.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000232316.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000232388.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000232455.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000232470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000232490.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000232586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000232611.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000232618.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000232645.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000232692.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000232827.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000232827.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000232891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000232912.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000233006.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000233013.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000233060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000233069.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000233081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000233137.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000233143.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000233203.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000233223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000233250.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000233261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000233330.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000233368.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000233421.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000233529.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000233532.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000233547.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000233554.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000233593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000233621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000233625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000233627.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000233627.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000233654.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000233694.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000233695.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000233785.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000233806.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000233818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000233847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000233903.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000233922.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000233926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000234050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000234142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234155.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000234156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234183.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000234197.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234252.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000234255.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000234290.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234352.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000234393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234478.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000234601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234616.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234694.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000234705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000234793.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000234817.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234818.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000234899.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234899.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000234942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000234996.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000235079.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000235085.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000235119.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000235123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000235192.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000235204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000235319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235326.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000235326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000235335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235358.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000235373.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000235398.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235437.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000235470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000235481.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000235527.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235527.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000235566.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000235641.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000235660.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000235660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000235724.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000235724.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000235726.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000235790.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235884.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000235890.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000235910.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000235954.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000235999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000236065.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000236091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000236137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000236144.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000236153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000236199.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000236206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236242.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236255.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000236255.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000236266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000236299.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000236305.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000236305.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000236318.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236345.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236383.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000236383.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000236426.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236432.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000236510.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236601.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000236618.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000236618.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236760.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000236799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000236861.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000236869.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000236871.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000236871.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000236896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000237017.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000237250.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000237250.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000237253.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000237328.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000237356.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000237380.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000237422.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000237438.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000237438.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000237461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000237481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000237499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000237525.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000237596.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000237605.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000237646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000237646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000237857.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000237886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000237980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000237989.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000238005.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000238106.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000238123.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000238123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000238141.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000238160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000238186.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000238221.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000238290.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000239002.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000239353.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000239377.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000239462.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000239608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000239641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000239653.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000239906.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000239920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000240005.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000240057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000240063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000240063.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000240137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000240211.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000240401.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000240687.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000240710.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000240754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000240907.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000240990.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000241155.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000241158.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000241280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000241313.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000241313.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000241316.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000241544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000241770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000241860.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000241933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000241933.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000242082.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000242282.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000242282.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000242375.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000242516.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000242569.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000242687.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000242687.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000242770.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000243018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000243055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000243144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000243179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000243629.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000243926.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000244041.3 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000244063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000244198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000244268.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000244327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000244479.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000244558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000244968.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000244998.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000245275.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000245479.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000245532.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000245532.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000245556.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000245667.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000245750.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000245904.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000246090.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000246228.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000246273.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000246430.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000246523.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000246526.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000246548.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000246662.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000246695.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000246763.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000246982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000247095.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000247095.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000247137.4 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000247228.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000247287.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000247402.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000247416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000247498.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000247735.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000247809.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000248008.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248019.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248027.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000248100.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000248103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248115.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000248388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000248416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248544.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000248587.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000248714.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248773.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000248779.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000248779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248846.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248858.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000248936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000248936.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000249001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000249035.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000249112.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000249167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000249241.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000249249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000249252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000249252.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000249293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000249307.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000249328.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000249379.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000249379.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000249395.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000249417.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000249456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000249464.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000249484.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000249532.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000249593.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000249621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000249635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000249664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000249996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000250015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000250062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000250069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000250073.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000250102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000250159.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000250222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000250234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000250241.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000250274.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000250286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000250295.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000250303.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000250312.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000250326.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000250337.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000250362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000250397.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000250432.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000250490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000250519.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000250548.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000250608.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000250635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000250751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000250770.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000250786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000250802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000250903.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000250938.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000250950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000250958.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000251003.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000251009.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000251031.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000251034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000251131.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000251143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000251143.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000251151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000251175.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000251175.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000251179.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000251330.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000251555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000251562.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000251661.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000251675.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000253111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000253125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000253172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000253227.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000253263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000253374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000253390.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000253390.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000253392.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000253399.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000253399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000253433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000253477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000253507.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000253583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000253649.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000253658.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000253706.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000253741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000253865.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000253892.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000253893.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000253930.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000253961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000253972.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000253982.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000254003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254003.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000254027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000254057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254139.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254162.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000254164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000254165.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000254231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254231.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254238.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000254258.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000254263.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000254286.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000254295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254333.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000254340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000254341.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254363.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000254414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254414.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000254461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254480.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254480.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000254485.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000254495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000254538.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000254577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254606.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000254638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254802.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000254814.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254854.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254855.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254911.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000254964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000254973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000254981.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000254990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000254991.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255026.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000255089.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000255094.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000255094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255120.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000255125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255158.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000255164.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000255201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255318.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000255320.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000255322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000255325.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255326.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000255348.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000255355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000255375.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255400.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000255421.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000255478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000255520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000255559.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000255559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000255621.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000255669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000255670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000255864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000255893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000255931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000255968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000255970.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000255989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000256006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000256008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000256083.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000256084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000256124.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000256146.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000256196.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000256448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000256458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000256481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000256603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000256705.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000256824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000256894.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000256944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000256967.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000257056.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000257135.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000257139.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000257193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000257202.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000257219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000257221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000257221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000257222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000257270.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000257283.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000257298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000257410.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000257433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000257433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000257433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000257475.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000257496.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000257497.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000257534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000257556.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000257613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000257660.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000257696.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000257696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000257740.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000257815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000257859.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000257906.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000257910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000257913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000257925.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000257953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258077.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000258199.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000258260.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000258301.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000258303.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000258317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258325.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000258344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000258410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258428.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000258441.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000258442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000258561.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000258592.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000258646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258658.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000258658.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000258711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258711.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000258725.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000258731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258813.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000258851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000258857.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000258857.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000258891.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258926.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000258929.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258940.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000258940.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000258942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000258955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259005.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259031.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259088.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259115.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259146.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259206.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259230.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000259242.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000259251.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259298.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000259310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259417.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259417.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259424.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259442.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000259445.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259450.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259453.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000259473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259488.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259504.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000259514.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259644.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000259659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259673.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259687.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000259692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259701.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000259702.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000259705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259716.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000259732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259732.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000259744.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259755.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259782.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000259869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259876.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000259899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000259899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000259933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000259986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000260017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260022.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000260037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000260065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000260093.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000260100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260101.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000260160.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260219.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000260261.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260281.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000260288.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260317.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260368.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260368.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000260398.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260411.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000260436.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260468.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000260488.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260528.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260579.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260585.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000260588.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000260621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260626.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000260630.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000260635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260643.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260655.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260671.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000260743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260793.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260793.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000260805.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260830.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000260831.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000260841.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260871.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000260874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260932.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000260936.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000260941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000260953.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000260977.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000260978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261000.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261003.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000261039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261079.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261087.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000261105.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261114.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000261141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261183.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261188.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000261204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261220.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261220.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261238.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261242.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000261251.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000261270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261338.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261357.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261386.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261390.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261392.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000261423.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000261431.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000261437.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261438.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000261441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261441.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000261485.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000261488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261488.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000261488.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261529.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000261533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261572.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261578.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000261582.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000261589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261595.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000261596.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261596.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000261597.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000261632.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000261632.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000261644.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261670.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000261690.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261712.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261723.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000261730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000261730.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261731.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000261783.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261799.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261804.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261824.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261827.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261839.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000261842.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000261879.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000261879.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000261886.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000261916.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000262115.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000262223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000262228.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000262312.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000262313.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000262339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000262529.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000262662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000262663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000262668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000262678.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000262678.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000262686.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000262692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000262714.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000262714.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000262833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000262833.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000262837.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000262848.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000262873.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000262877.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000262979.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000263069.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000263080.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000263164.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000263272.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000263280.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000263316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000263370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000263388.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000263466.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000263470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000263531.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000263627.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000263674.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000263727.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000263731.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000263843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000263860.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000263874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000263923.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000264007.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000264112.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000264188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000264235.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000264290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000264304.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000264304.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000264448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000264456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000264548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000264735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000264812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000264914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000264920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000264937.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000264968.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000265008.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000265010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000265055.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000265091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000265222.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000265342.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000265394.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000265399.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000265413.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000265458.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000265478.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000265490.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000265666.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000265688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000265888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000265888.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000266040.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000266126.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000266378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000266401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000266401.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000266456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000266469.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000266469.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000266538.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000266538.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000266601.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000266651.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000266654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000266783.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000266901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000266921.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000266922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000266922.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000266934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000266934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000266947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000266970.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000266975.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000266976.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000266983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000266993.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000266994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267016.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000267058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267067.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000267082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267082.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000267093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267104.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267104.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000267108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000267117.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000267121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000267123.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267149.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000267150.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000267161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267166.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267191.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267192.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000267201.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000267207.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267219.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000267265.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000267277.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267302.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000267304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267316.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000267348.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267383.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267395.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267446.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000267475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000267498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267510.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267575.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267655.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000267655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267666.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000267764.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000267808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000267808.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000267834.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000267858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267871.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000267905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000268049.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000268061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000268066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000268066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000268087.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000268095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000268199.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000268199.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000268199.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000268204.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000268204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000268230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000268340.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000268364.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000268392.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000268499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000268543.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000268549.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000268655.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000268707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000268746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000268912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000268970.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000268987.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000269202.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000269463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000269473.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000269481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000269560.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000269656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000269680.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000269688.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000269694.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000269892.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000269899.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000269934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000269946.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000269946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000269951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000269951.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000269971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000269978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000270010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000270012.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000270031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000270041.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000270066.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000270068.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000270081.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000270105.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000270109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000270109.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000270116.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000270127.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000270137.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000270140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000270165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000270344.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000270362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000270426.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000270462.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000270522.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000270571.2 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000270589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000270599.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000270607.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000270726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000270750.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000270761.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000270792.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000270949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000270951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000270964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000270996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000270996.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000271032.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000271119.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000271127.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000271185.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000271199.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000271204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000271218.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000271259.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000271324.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000271344.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000271401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000271430.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000271533.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000271576.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000271579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000271646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000271659.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000271715.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000271780.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000271781.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000271803.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000271803.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000271835.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000271857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000271874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000271904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000271914.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000271931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000271973.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000271978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000271983.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000271992.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000271992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272030.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000272087.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000272097.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272121.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000272144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272198.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272198.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000272221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272239.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272264.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272273.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272273.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272282.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272334.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000272341.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272373.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272403.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272432.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272432.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000272440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272440.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272505.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272524.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272525.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272556.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Linsitinib |
ENSG00000272564.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272564.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000272574.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272659.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000272662.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000272666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272688.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272699.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272709.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272732.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000272744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272754.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272754.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000272760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272788.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272788.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000272788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000272792.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272792.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272823.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000272832.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000272864.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272871.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000272902.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000272940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000272953.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000272966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000272989.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000273002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273004.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000273014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000273017.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000273027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000273065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000273100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000273104.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000273123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273129.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000273133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Linsitinib |
ENSG00000273145.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000273156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Linsitinib |
ENSG00000273160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273175.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Linsitinib |
ENSG00000273183.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000273188.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Linsitinib |
ENSG00000273190.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000273203.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000273230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000273232.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000273233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000273305.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Linsitinib |
ENSG00000273308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000273309.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000273321.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Linsitinib |
ENSG00000273366.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Linsitinib |
ENSG00000273373.1 |
Predicted lncRNA |
Sarcoma |
|
| Linsitinib |
ENSG00000273374.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Linsitinib |
ENSG00000273486.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Linsitinib |
ENSG00000273488.1 |
Predicted lncRNA |
Sarcoma |
|
